FDA
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Announces Positive Results from the Ongoing STS101 ASCEND Phase 3 Open-label, Long-term Safety Trial
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Announces Poster Presentations on the American Academy of Neurology 2020 Science Highlights Virtual Platform
-
-
-
-
-
-
-
Satsuma Pharmaceuticals Reports Third Quarter 2019 Financial and Business Results
322,096 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

